The facility in Kabul, Afghanistan, is proving to be a key player in the worldwide supply chain for Abacavir Sulphate API. This Afghan manufacturing capability represents a significant step onward for the Afghan pharmaceutical market and presents a special opportunity to mitigate need on foreign